India: The Drugs And Cosmetics (Amendment) Bill, 2013: Regulations For Medical Devices And Conduct Of Clinical Trial

In the last few years, the Indian pharmaceutical sector has seen an immense growth both in terms of domestic and international stratum and recognized itself as one of the largest in terms of volume. The emerging market of medical devices is one of the biggest contributions behind the growth in this overall pharmaceutical sector in India.

Further, the approval of 100 % FDI in the pharmaceutical sector under the automatic route for Greenfield investments as well as under the Government approval route for investments in existing companies1 has made India as one of the emerging markets for direct investment in pharmaceutical sector. Various large multinational pharmaceutical companies have shown interest to enter into acquisitions and tie-ups with Indian pharmaceutical companies to make attractive investment for the biggest reason being that India offers them potentiality and ability to manufacture generic drugs and medical devices at a comparatively low cost while at the same time maintaining desired quality.

In spite of such an emerging stride in the Indian market of medical devices, until lately, the medical device sector has remained unregulated and functioning in absence of any standards for the devices used in the healthcare sector. However, the recent initiative of the Indian Government by introducing the Drugs and Cosmetics (Amendment) Bill, 2013 [the Bill 2013] would act like a boon to the industry and would bring along, positive hopes to achieve an assurance of the best and safest medical technologies in the country.

In 2006, the Government realized that the country requires a legislation to bring under its control the safety and performance of medical devices and accordingly introduced the Medical Devices Regulation Bill, 2006 with the intention to consolidate laws related to medical devices and establish the Medical Device Regulatory Authority of India (MDRA). This Bill was aimed at establishing and maintaining a national system of controls for the quality, safety and availability of medical devices in India. However, the above Bill has not been enacted by the Parliament.

At present, provisions related to import, manufacture, distribution and sale of medical devices are covered under the Drugs and Cosmetics Act, 1940 ["Act"] and the Drugs and Cosmetics Rules, 1945 ["Rules"]. However, the said Act and the Rules cover only notified Medical Devices2. Notified medical devices are those medical devices which have been notified as drugs by the Government of India. Notified Medical Devices are currently covered under the definition of Drugs under the Act under Section 3 (b) (iv) which reads as follow:

"b) "drug" includes—

...(iv) such devices intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, as may be specified from time to time by the Central Government by notification in the Official Gazette, after consultation with the Board "

The Drugs and Cosmetics (Amendment) Bill , 2013

The most recent measure taken up by the Government on 29 August, 2013 is the introduction of the Drugs and Cosmetics (Amendment) Bill, 2013. The Bill 2013 interalia contains a separate Chapter for regulatory provisions for import, manufacture, sale, distribution and export of medical devices and for regulating conduct of clinical trials in India. This Bill 2013 also provides provisions for setting up of a Central Drugs Authority (CDA) as an overarching body for regulation of drugs and cosmetics. The Authority shall have power to issue a license or a certificate, as the case may be, for the manufacture for sale or for export of drugs specified in the Third Schedule to the Act.

Regulations on the Medical Devices

In terms of medical device, the Bill 2013 has thrown light on the definition of the term "medical device" on the same approach as that of MDRB. In the Bill 2013, medical device includes additionally the instruments for diagnosis, monitoring, treatment, alleviation of, or assistance for handicaps also. Once the Bill is passed, the definition of medical device will no longer be read in the light of the definition of "drugs" as specified under Section 3(b)(iv) of the Drugs and Cosmetics Act, 1940 which creates ambiguity and restricts the ambit of medical device only to notified medical devices.

Provisions related to import, manufacture, sale, distribution and export of medical devices

The import, manufacture, sale, distribution, export and labelling of notified medical device is regulated under the Drugs and Cosmetics Act, 1940. However, it is felt by the industry and regulatory authorities that provisions related to drugs cannot be applicable entirely for medical devices. In this context, the present Bill 2013 is an attempt to frame provisions which are specific for medical devices. For instance, the Bill 2013 specifies the conditions under which medical devices shall be deemed to be misbranded, adulterated, spurious or not of standard quality. In order to define when a medical device shall be deemed to be misbranded under Section 7 C of the Bill, it has made new insertion of the term "functional value" and states as "............if it is made to appear of better or greater therapeutic or functional value than it really is..." Similarly, a new sub-clause (e) has been inserted in Section 7D of the Bill 2013 which defines when a medical device shall be deemed to be adulterated drugs and the same reads as "if its containers is composed, in whole or in part, of any deleterious substance which may render it dangerous to use or injurious to health."

The Bill 2013 restricts any person to import or manufacture for sale or for export by himself or by any person on his behalf those medical devices which are not of standard quality or misbranded, adulterated, spurious under Section 7F and it has also inserted a new sub-clause that includes restriction for import or manufacture for sale or for export any software or part or component or instrument or the list of the software or part or ingredient or instrument contained in it, unless displayed in the prescribed manner on the label or container.

The Bill 2013 has also laid down the penalties for the offences related to import, manufacture for sale, stocking, exhibiting, offering for sale of medical devices or distribution or export of any adulterated, spurious or not of standard quality medical devices and penalties related to grievous injury or death caused due to use of such medical devices. Further, Section 7 M specifies provisions for confiscation of medical device, implements, machinery, receptacles, packages, coverings, animals, vehicles, vessels or other conveyances of persons convicted for offences under Chapter II A of the Bill 2013.

Advisory body pertaining to the matters related to the medical devices

The Bill 2013 includes Section 5A which specifies the establishment of a Medical Devices Technical Advisory Board which will act as an advisory body to the Central Government, the Central Drugs Authority and State Governments on technical matters pertaining to medical devices, arising out of the administration of the Bill 2013 and to carry out other functions assigned to it by or under the purview of the Bill 2013.

Similarly, another advisory committee called "the Drugs, cosmetics and Medical Devices Consultative Committee" may also be constituted by the Central Government which would require to provide advice to the Central Government, the Central Drugs Authority and State Governments on matters pertaining to secure uniformity throughout India in the administration of the provisions of the Bill 2013.

Formation of the Central Drugs Authority (CDA)

Further, the Bill 2013 has inserted Chapter I A that specifies the structurization of new regulatory authority- the Central Drugs Authority. The CDA will be empowered to act like a regulatory check on the functioning of the Central Licensing Authority and the State Licensing Authorities. In fact, in order to attempt for diligent functioning of these authorities, CDA can assess periodically the functioning of the authorities and further specify regulations, guidelines, norms, structures and requirement for effective functioning. In the recent years, there have been several reports of irregularities in issuance of permissions, licenses or certificates and permits by the State authorities. Keeping in view such circumstances, the Bill 2013 empowers the CDA to review, suspend or cancel any permission, license or certificate issued by the Central Licensing Authority or the State Licensing Authorities and it extends to issue, renew, suspend or cancel such license, certificate, approvals and permissions for conducting clinical trial as well.

Regulations with respect to conduct of clinical trial in the Bill 2013

The insertion of Chapter IB on the provisions related to clinical trial will strengthen statutory protections related to the serious risk involved in the conduct of clinical trial. A new insertion of provision specifies that the CLA may, in public interest, abbreviate, defer or omit the pre-clinical and clinical data requirements for approval of clinical trial of drugs indicated in life threatening or serious diseases or diseases of special relevance to the country. Further, Bill 2013 has inserted provisions related to stringent punishment for the companies conducting clinical trial without permission or in contravention of any provisions specified in the Bill 2013 and provisions related to compensation for adverse effects of clinical trial suffered by the participants of clinical trial. The Bill 2013 also lays down that the companies which are held responsible to pay compensation to the victims of clinical trial who suffered injury or death as a result of the adverse effect of the clinical trial companies, fails to do so, shall be punished with imprisonment which may extend to two years and with fine which shall not be less than twice the amount of the compensation.


The emerging stride of Indian pharmaceuticals is not only helping in the growth of the economy of the country but also bringing the concept of globalization more nearer. The Bill 2013 would undoubtedly provide a set of regulations which would define the standards and quality of medical devices to be available in the market.

The Bill 2013, once passed, will govern import, export, manufacture, distribution and sale of the medical devices and conduct of the clinical trials in India. Further, the Bill 2013 would completely overhaul all existing standards and lead to systematize the activities in the market related to medical devices and consequently, it will attract more international medical device companies to show willingness to manufacture products locally or import medical devices because of their assured quality and standard. Further, provisions relating to conduct of clinical trials which have been addressed extensively are a significant step towards implementation of Good Clinical Practice- a practice appreciated worldwide. Precisely, this Bill 2013 would not only play the role of a strict vigilance on conducts of the companies dealing with medical devices and clinical trials but also have a deterrent effect on those companies for not adhering to the standards formulated for the medical devices and procedures of conducting safe clinical trials.



2 List of notified medical devices is available on CDSCO website at

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions